ALL
Pharma?in?China
Pharma?Experts
Market News
Products Guide
Brand Story
-
Provention Bio tees up for $50M IPO
fiercebiotech
May 16, 2018Provention Bio has filed to raise up to $50 million in its Nasdaq IPO, which will bankroll several clinical programs, including a pair of inflammatory bowel disease assets it picked up from Janssen last fall. -
Provention Bio Announces Licensing Agreements with Janssen
americanpharmaceuticacreview
September 22, 2017Provention Bio has entered into agreements with Janssen Pharmaceutica NV and Janssen Sciences Ireland UC [Janssen] to in-license two clinical-stage assets
Pharma Sources Insight January 2025
